Literature DB >> 26667834

The Effector Protein BPE005 from Brucella abortus Induces Collagen Deposition and Matrix Metalloproteinase 9 Downmodulation via Transforming Growth Factor β1 in Hepatic Stellate Cells.

Paula Constanza Arriola Benitez1, Diego Rey Serantes2, Claudia Karina Herrmann2, Ayelén Ivana Pesce Viglietti1, Silvia Vanzulli3, Guillermo Hernán Giambartolomei1, Diego José Comerci2, María Victoria Delpino4.   

Abstract

The liver is frequently affected in patients with active brucellosis. In the present study, we identified a virulence factor involved in the modulation of hepatic stellate cell function and consequent fibrosis during Brucella abortus infection. This study assessed the role of BPE005 protein from B. abortus in the fibrotic phenotype induced on hepatic stellate cells during B. abortus infection in vitro and in vivo. We demonstrated that the fibrotic phenotype induced by B. abortus on hepatic stellate (LX-2) cells was dependent on BPE005, a protein associated with the type IV secretion system (T4SS) VirB from B. abortus. Our results indicated that B. abortus inhibits matrix metalloproteinase 9 (MMP-9) secretion through the activity of the BPE005-secreted protein and induces concomitant collagen deposition by LX-2 cells. BPE005 is a small protein containing a cyclic nucleotide monophosphate binding domain (cNMP) that modulates the LX-2 cell phenotype through a mechanism that is dependent on the cyclic AMP (cAMP)/protein kinase A (PKA) signaling pathway. Altogether, these results indicate that B. abortus tilts LX-2 cells to a profibrogenic phenotype employing a functional T4SS and the secreted BPE005 protein through a mechanism that involves the cAMP and PKA signaling pathway.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26667834      PMCID: PMC4730569          DOI: 10.1128/IAI.01227-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

2.  Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A.

Authors:  Alexander C Zambon; Lingzhi Zhang; Simon Minovitsky; Joan R Kanter; Shyam Prabhakar; Nathan Salomonis; Karen Vranizan; Inna Dubchak; Bruce R Conklin; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 3.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

4.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

5.  Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: In vitro study.

Authors:  Naoya Ikeda; Soichiro Murata; Takehito Maruyama; Takafumi Tamura; Reiji Nozaki; Takuya Kawasaki; Kiyoshi Fukunaga; Tatsuya Oda; Ryoko Sasaki; Masato Homma; Nobuhiro Ohkohchi
Journal:  Hepatol Res       Date:  2011-10-11       Impact factor: 4.288

6.  In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate.

Authors:  H Tullberg-Reinert; G Jundt
Journal:  Histochem Cell Biol       Date:  1999-10       Impact factor: 4.304

7.  cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.

Authors:  Xiaoqiu Liu; Shu Qiang Sun; Aviv Hassid; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2006-09-07       Impact factor: 4.436

8.  Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

9.  Brucella modulates secretory trafficking via multiple type IV secretion effector proteins.

Authors:  Sebenzile Myeni; Robert Child; Tony W Ng; John J Kupko; Tara D Wehrly; Stephen F Porcella; Leigh A Knodler; Jean Celli
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

10.  Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum.

Authors:  Jean Celli; Chantal de Chastellier; Don-Marc Franchini; Javier Pizarro-Cerda; Edgardo Moreno; Jean-Pierre Gorvel
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

View more
  10 in total

1.  Brucella abortus Promotes a Fibrotic Phenotype in Hepatic Stellate Cells, with Concomitant Activation of the Autophagy Pathway.

Authors:  Paula Constanza Arriola Benitez; Ayelén Ivana Pesce Viglietti; Claudia Karina Herrmann; Vida A Dennis; Diego José Comerci; Guillermo Hernán Giambartolomei; María Victoria Delpino
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

2.  A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to Brucella abortus Intracellular Lifestyle.

Authors:  María I Marchesini; Susana M Morrone Seijo; Francisco F Guaimas; Diego J Comerci
Journal:  Front Cell Infect Microbiol       Date:  2016-11-16       Impact factor: 5.293

3.  Brucella abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent IL-1β Production.

Authors:  Paula Constanza Arriola Benitez; Ayelén Ivana Pesce Viglietti; Marco Tulio R Gomes; Sergio Costa Oliveira; Jorge Fabián Quarleri; Guillermo Hernán Giambartolomei; María Victoria Delpino
Journal:  Front Immunol       Date:  2020-01-21       Impact factor: 7.561

Review 4.  Uncovering the Hidden Credentials of Brucella Virulence.

Authors:  R Martin Roop; Ian S Barton; Dariel Hopersberger; Daniel W Martin
Journal:  Microbiol Mol Biol Rev       Date:  2021-02-10       Impact factor: 11.056

5.  The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats.

Authors:  Abdelghany Hassan Abdelghany; Mohammad A BaSalamah; Shakir Idris; Jawwad Ahmad; Bassem Refaat
Journal:  J Transl Med       Date:  2016-09-29       Impact factor: 5.531

Review 6.  Proteomics of Brucella.

Authors:  Ansgar Poetsch; María Inés Marchesini
Journal:  Proteomes       Date:  2020-04-22

7.  Dose-Dependent Antifibrotic Effect of Chrysin on Regression of Liver Fibrosis: The Role in Extracellular Matrix Remodeling.

Authors:  Cornel Balta; Alina Ciceu; Hildegard Herman; Marcel Rosu; Oana Maria Boldura; Anca Hermenean
Journal:  Dose Response       Date:  2018-08-08       Impact factor: 2.658

8.  Evaluation of the General Organization of Veterinary Services control program of animal brucellosis in Egypt: An outbreak investigation of brucellosis in buffalo.

Authors:  H I Hosein; Hoda Mohamed Zaki; Nesreen Mohamed Safwat; Ahmed M S Menshawy; Sherin Rouby; Ayman Mahrous; Bahaa El-Deen Madkour
Journal:  Vet World       Date:  2018-06-06

Review 9.  Immunopathogenesis of Hepatic Brucellosis.

Authors:  Guillermo Hernán Giambartolomei; María Victoria Delpino
Journal:  Front Cell Infect Microbiol       Date:  2019-12-20       Impact factor: 5.293

Review 10.  The VirB System Plays a Crucial Role in Brucella Intracellular Infection.

Authors:  Xue Xiong; Bowen Li; Zhixiong Zhou; Guojing Gu; Mengjuan Li; Jun Liu; Hanwei Jiao
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.